Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma-glutamyl carboxylase (GGCX) is an integral membrane enzyme located in the rough endoplasmic reticulum. It catalyzes the posttranslational modification of specific glutamate residues to gamma-carboxyglutamate (Gla) in vitamin K-dependent proteins. This modification is essential for the biological activity of these proteins, many of which are involved in blood coagulation, bone metabolism, vascular calcification, and other physiological processes. GGCX uses reduced vitamin K, carbon dioxide, and oxygen as cofactors to carboxylate glutamate residues. Mutations in GGCX can cause bleeding disorders and connective tissue abnormalities.
Vitamin K antagonists inhibit GGCX by interfering with the vitamin K cycle, thereby reducing the carboxylation of vitamin K-dependent proteins.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-glutamyl carboxylase (GGCX).